Menu

Close

Stories & News

Resources

Stay Informed

Stay Informed

September 17, 2025
Our R&D Engine: Proven Success in Bringing Revolutionary Drugs to Market
 Stories
September 10, 2025
Pioneering the Future of Healthcare: Pfizer’s AI Advantage
 Stories
August 26, 2025
In Conversation with Andrew Baum: Exploring Pfizer’s Long-Term Vision
 Stories
August 21, 2025
Expanding Pfizer’s Oncology Portfolio: Insights from Our Latest Pfizer Pflash Webcast Stories
August 7, 2025
Here's What Analysts Asked About Pfizer's Strategy & Priorities on Its Q2 2025 Earnings Call Stories
August 5, 2025
Pfizer Delivers A Strong Q2 2025 and Raises Full Year EPS Guidance Stories
July 10, 2025
Inside Pfizer's Purpose-Driven Strategy: 2024 Impact Report Stories

July 2, 2025

Spotlight on Breast Cancer: Insights from June's Pfizer Pflash Webcast Stories

June 26, 2025

The Future of Pfizer's Scientific Strategy: A Q&A with Susan Desmond-Hellmann, MD, the new Chair of the Pfizer Board's Science and Technology Committee Stories

June 17, 2025

Inside the Room: Key Questions from the Goldman Sachs Annual Global Healthcare Conference Stories
June 10, 2025
Showcasing Our Oncology Innovation: Insights from Chief Oncology Officer Dr. Jeff Legos Stories
May 7, 2025
Here’s What Analysts Asked About Pfizer’s Strategy & Priorities on its Q1 2025 Earnings Call Stories

April 29, 2025

Pfizer Reports Solid First-Quarter 2025 Financial Results and Reaffirms Full-Year Guidance Stories

April 3, 2025

Quiz: Did You Listen to Season 4 of Pfizer’s ‘Science Will Win’ Podcast? Stories

March 12, 2025

Inflammation and Immunology Discovery: A Day in the Life of Pfizer Scientist Dr. Thomas Wynn Stories

March 7, 2025

Pfizer Marks 16 Years of Annual Dividend Increases with 345th Consecutive Quarterly Dividend Payments Stories

February 12, 2025

Here’s What Analysts Asked About Pfizer’s Research and Development Strategy as Part of its Q4-FY 2024 Earnings Call Stories

February 6, 2025

2024 Key Milestones Stories

February 4, 2025

Pfizer Reports Strong Q4 and Full-Year 2024 Results; Strengthens Company for the Future Stories

January 22, 2025

Pfizer’s 2025 Priorities: A Roadmap to Innovation and Excellence Stories

December 20, 2024

Advancing Oncology Innovation: Celebrating One Year of Pfizer + Seagen Stories

December 19, 2024

Communicating Pfizer’s Value: A Conversation with Francesca DeMartino Stories

October 29, 2024

Pfizer Delivers Strong Third-Quarter 2024 Financial Results and Raises 2024 Guidance Stories

October 15, 2024

Expanding Our Governance: Meet the Newest Members of Pfizer’s Board of Directors Stories

July 30, 2024

Pfizer Delivers Strong Second-Quarter 2024 Financial Results and Raises 2024 Guidance Stories

June 28, 2024

Celebrate Our 175th Anniversary by Testing Your Pfizer-Knowledge! Stories

June 24, 2024

Celebrating 175 Years of Changing Lives at Pfizer Stories

May 29, 2024

A Conversation with Chris Boshoff: Leading Pfizer’s Oncology Organization Stories

May 20, 2024

World Clinical Trials Day 2024: Pfizer’s Commitment to Improving the Clinical Trial Experience Stories

May 1, 2024

Pfizer Reports Solid First-Quarter 2024 Financial Results Stories

April 8, 2024

Quiz: Did You Review Pfizer’s 2023 Impact Report? Stories

March 14, 2024

Pfizer’s Journey Towards a Better Tomorrow: 2023 Impact Report Stories

March 7, 2024

Pfizer’s Oncology Innovation Day: Company Launches Strategy to Deliver Next Era of Meaningful Treatments for Cancer Patients Stories

February 9, 2024

Pfizer’s Albert Bourla Talks Seagen Acquisition on CNBC’s Mad Money with Jim Cramer Stories

February 5, 2024

A Year in Review Stories

January 30, 2024

Pfizer Reports Fourth Quarter and Full-Year 2023 Results; Enters 2024 With a Solid Foundation Stories

November 14, 2023

How much do you know about Pfizer? Stories

October 31, 2023

Pfizer Reports Third Quarter Results Stories

October 12, 2023

How Pfizer’s Women Leaders Are Breaking Barriers in Vaccine Science Stories

October 2, 2023

Pfizer’s Rocky Mount Facility Restarts Production: First Step Towards Full Recovery After Tornado   Stories

September 27, 2023

Engaging Our Shareholders: Pfizer Announces New Chief Investor Relations Officer Stories

September 5, 2023

Pfizer’s Approach to Incorporating Sustainability in the Development of Medicines Stories

August 1, 2023

Pfizer’s Second Quarter: Solid Financial Performance and Several Pipeline Advances Stories

July 14, 2023

Pfizer’s Long Streak of Returning Capital to Investors Stories

June 6, 2023

Pfizer’s Commitment to Improving Diversity in Clinical Trials: A Quiz Stories

May 2, 2023

Pfizer’s First-Quarter Results: A Solid Start to the Year Stories

April 12, 2023

A New Era of Innovations in Oncology Stories

March 31, 2023

Investing Capital in the Next Generation of Potential Breakthroughs: A Conversation with Pfizer’s Chief Business Innovation Officer Stories

March 16, 2023

Pfizer is Making Continued Progress on its ESG Strategy: 2022 ESG Report Stories

March 13, 2023

Enhancing Pfizer’s Position in Oncology Stories

February 3, 2023

Marking A Year’s Milestones Stories

January 31, 2023

A Record-Breaking Year and Strong Fourth Quarter for Pfizer Stories

January 20, 2023

Pfizer Expands Commitment to Creating a “Healthier World” Stories

January 3, 2023

Potential for Future Growth Through Internal Innovation Stories

December 19, 2022

A 60-Year Quest for An RSV Vaccine: A Conversation with Dr. William Gruber Stories

November 18, 2022

Pfizer Supports Florida Residents with Hurricane Ian Relief Efforts Stories

November 1, 2022

Pfizer Third Quarter Sees Multiple Pipeline Advances Stories

October 20, 2022

Confronting the Challenge of Climate Change: Pfizer’s Sustainability Efforts Stories

September 23, 2022

Developing a Potential mRNA Influenza Vaccine Stories

September 9, 2022

One Step Closer in the Global Fight Against Respiratory Syncytial Virus (RSV) Stories

September 8, 2022

Putting Capital to Work Stories

August 15, 2022

Lyme Disease Vaccine Candidate Phase 3 Trial to Begin Stories

July 28, 2022

Pfizer’s Second Quarter Sees Historic Sales and Bold Goals Stories

July 12, 2022

“Investments to Improve the Lives of Patients”: A Conversation with Pfizer’s New CFO Stories

June 14, 2022

Access and Affordability: How Pfizer Is Impacting People with Breakthrough Medicines and Vaccines Stories

June 2, 2022

Seeking Breakthrough Therapies for Immuno-Inflammatory Diseases Stories

May 24, 2022

Better Medicines through Health Equity: Talking to Chief Medical Officer Dr. Aida Habtezion Stories

May 3, 2022

Pfizer Results: Strong Performance and A Commitment to Be A Force for Good Stories

April 25, 2022

Pfizer Is Using AI to Discover Breakthrough Medicines Stories

March 17, 2022

The Confidence to Rise to Any Challenge: Pfizer’s 2021 ESG Report Stories

March 14, 2022

Pfizer’s Twelve Years of Dividend Increases Stories

March 3, 2022

On Rare Diseases Day, New Partnerships and Investments Could Deliver Potential Breakthroughs Stories

March 1, 2022

Using Viruses to Fight Cancer: A New Approach to Treating Solid Tumors Stories

February 21, 2022

A “Fundamentally Changed” Company: Pfizer Reports Strong 2021 Earnings Stories

February 18, 2022

Variant-Based Vaccine Trial Key to Virus Vigilance Stories

January 27, 2022

Pfizer’s Roadmap for mRNA, A “Game-Changer Technology” Stories

January 24, 2022

Pfizer Makes Progress on Multiple Fronts with COVID-19 Treatment Candidate Stories

December 10, 2021

Two Billion Doses by the End of 2022: Pfizer’s Commitment to Equitable Access Stories

November 10, 2021

A Pill That Could Potentially Save Lives: Pfizer Treatment Reduced Risk of Hospitalization or Death from COVID-19 in Interim Analysis Stories

November 9, 2021

CEO Albert Bourla on Transforming Pfizer Stories

November 2, 2021

Pfizer Inc. Third Quarter 2021 Financial Results Stories

October 28, 2021

A Potential Breakthrough in the Fight Against RSV? Pfizer’s Vaccine Candidate Enters Phase 3 Trials Stories

October 20, 2021

What Can You Tell Me About Potential COVID-19 Vaccines in Children? Hear About Some of Pfizer’s Research Stories

October 15, 2021

Shot of a Lifetime: How Pfizer and BioNTech Developed and Manufactured a COVID-19 Vaccine in Record Time Stories

October 5, 2021

The Company You Keep: Pfizer Partners for Success Stories

September 28, 2021

Pfizer: Improving the Pace of Innovation Stories

September 20, 2021

Pfizer Supports Affordable Access Through Biosimilars Stories

September 15, 2021

Pfizer’s Streak of Returning Cash to Shareholders Stories

September 7, 2021

Pfizer’s Next Potential Breakthrough Vaccine Could Target The Flu Stories

Back

Loading

Page 1 of 42

Next

Loading
Corporate Pfizer Newsroom Loading

Forward-looking statements included herein are subject to substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. We encourage you to read our reports filed with the U.S. Securities and Exchange Commission (SEC), including the sections captioned “Risk Factors” and “Forward Looking Information and Factors that May Affect Future Results,” for a description of such substantial risks and uncertainties. These reports are available at pfizer.com and the SEC’s website.
 


Copyright © 2002 – 2025 Pfizer Investor Insights All rights reserved. This information—including product information—is intended only for residents of the United States. The products discussed herein may have different labeling in different countries. This website contains certain information about Pfizer, but may not contain all information that is material to Pfizer.